文献速递头颈部肿瘤放疗放疗物理与技术

外部验证的数字化决策支持工具用于颌骨放射性骨坏死时间风险分层

Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts.
PubMed 文献 · Radiother Oncol · 2025-04-11

本研究基于MD Anderson癌症中心1129例头颈癌放疗患者(198例ORNJ)的回顾性观察队列,训练Weibull加速失效时间模型预测ORNJ发生时间,并在Guy's and St. Thomas医院265例患者(92例ORNJ)中外部验证。模型显示男性、放疗前拔牙和D25%分别与ORNJ发生加快38%、27%和12%相关,调整时间比分别为0.62(p=0.11)、0.73(p=0.13)和0.88(p<0.005)。模型内部校准良好(集成Brier评分0.133,D校准p值0.998),72个月时Harrell's C-index为0.72。

要点

  • 男性、放疗前拔牙和D25%分别与ORNJ发生加快38%、27%和12%相关。
  • 模型72个月Harrell's C-index为0.72,集成Brier评分0.133。
  • 研究首次证明辐射剂量与ORNJ发生时间之间存在直接关系。

核心结论

  • 本研究首次证明辐射剂量与ORNJ发生时间之间存在直接关系,提供了 delivered dose 和患者相关因素对晚期效应(ORNJ)概率及生存期条件风险影响的新特征描述。

研究设计与样本

  • 回顾性临床观察队列研究,训练队列为MD Anderson癌症中心1129例头颈癌放疗患者(198例ORNJ),外部验证队列为Guy's and St. Thomas医院265例患者(92例ORNJ)。
  • 使用先前确定的剂量学、临床和人口学预测因子训练Weibull加速失效时间模型,并开发在线图形用户界面(GUI)进行正式利益相关者可用性测试。

主要发现

  • 男性与ORNJ发生加快38%相关,调整时间比为0.62(p=0.11)。
  • 放疗前拔牙与ORNJ发生加快27%相关,调整时间比为0.73(p=0.13)。
  • D25%与ORNJ发生加快12%相关,调整时间比为0.88(p<0.005)。
  • 模型内部校准良好,集成Brier评分为0.133,D校准p值为0.998。
  • 模型在72个月时具有最佳区分度,Harrell's C-index为0.72。

关键数值与推荐

  • 男性调整时间比0.62(p=0.11),对应ORNJ发生加快38%。
  • 放疗前拔牙调整时间比0.73(p=0.13),对应ORNJ发生加快27%。
  • D25%调整时间比0.88(p<0.005),对应ORNJ发生加快12%。
  • 集成Brier评分0.133,D校准p值0.998,72个月Harrell's C-index 0.72。

临床怎么用

  • 在线图形用户界面(GUI)已开发并经过正式利益相关者可用性测试,以促进模型的临床实施。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has important implications to monitor oral health in head and neck cancer (HNC) long-term survivors. METHODS: Data were retrospectively obtained for a clinical observational cohort of 1129 patients (198 ORNJ cases) with HNC treated with radiotherapy (RT) at The University of Texas MD Anderson Cancer Center. A Weibull Accelerated Failure Time model was trained on previously identified dosimetric, clinical and demographic predictors. External validation was performed using an independent cohort of 265 patients (92 ORNJ cases) treated at Guy's and St. Thomas' Hospitals. To facilitate clinical implementation of the model, an online graphical user interface (GUI) was developed, including formal stakeholder usability testing. RESULTS: Our model identified that gender (males), pre-RT dental extractions and D25% were associated with a 38 %, 27 % and 12 % faster onset of ORNJ, respectively, with adjusted time ratios of 0.62 (p = 0.11), 0.73 (p = 0.13) and 0.88 (p < 0.005). The model demonstrated strong internal calibration (integrated Brier score of 0.133, D-calibration p-value 0.998) and optimal discrimination at 72 months (Harrell's C-index of 0.72). CONCLUSION: This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose and patient-related factors not only on the probability of a late effect (ORNJ), but the conditional risk during survivorship.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Humbert-Vidan L, Kamel S, Wentzel A, et al. Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts. Radiother Oncol. 2025. PMID: 40222595. doi:10.1016/j.radonc.2025.110890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。